YPR071W is a 211-amino acid membrane protein (MW: ~24 kDa) with the sequence:
MQNGTEDKSN...TSENETL . Key features include:
The protein lacks essential gene status but shares a paralog (YIL029C) from single-locus duplication .
Commercial production utilizes multiple platforms:
Reconstitution requires sterile water (0.1-1.0 mg/mL) with glycerol supplementation for long-term stability .
While uncharacterized, recent studies suggest:
Genetic redundancy: Paralogs YPR071W/YIL029C may buffer membrane trafficking defects .
Spindle Pole Body (SPB) regulation: Artificially targeting YPR071W to SPBs induces overduplication phenotypes in mps3-1 spo7Δ mutants, hinting at structural roles in organelle biogenesis .
Membrane complex interactions: BioGRID data identifies 60 physical/genetic interactors, including:
| Interactor | Gene Name | Interaction Type | Functional Linkage |
|---|---|---|---|
| Emp24p | ERV25 | Physical | ER cargo receptor complex |
| Ted1p | YIL039W | Genetic | ER exit regulation |
| Rvs167p | RVS167 | Physical | Membrane curvature sensing |
Current uses focus on:
ELISA development: Commercial kits utilize recombinant YPR071W as antigen (CBM15 Cat.No: CSB-CF618594SVG) .
Trafficking studies: Co-purification with Emp24p/Erv25p homologs suggests utility in modeling ER export mechanisms .
Membrane protein crystallization: High-purity preparations enable structural studies despite absent functional data .
Key knowledge gaps include:
Native binding partners in S. cerevisiae
Subcellular localization under physiological conditions
Metabolic pathways involving YPR071W/YIL029C paralogs
Emerging hypotheses propose roles in lipid-modified protein trafficking or SPB assembly, warranting targeted mutagenesis studies . The protein’s pH stability (optimal at 8.0) and thermal resilience (-80°C storage) make it tractable for further biochemical assays .
KEGG: sce:YPR071W
STRING: 4932.YPR071W
YPR071W is an uncharacterized membrane protein in Saccharomyces cerevisiae (baker's yeast) consisting of 211 amino acids. According to available data, it has the UniProt accession number Q12346 and alternative ORF name YP9499.26. The protein contains a membrane-spanning domain and has a predicted molecular weight consistent with its amino acid sequence. The full amino acid sequence begins with MQNGTEDKSNIPARSNDDVLPPLAVRLTMKVMRLIFIGKMFAYSF and continues through to its C-terminal end . Structural prediction models suggest it likely contains multiple transmembrane domains, though high-resolution structural data remains unavailable.
For studying YPR071W, homologous expression in S. cerevisiae is typically the preferred approach as it provides the native cellular environment. The expression can be achieved using vectors with appropriate promoters (constitutive like PGAP or inducible like PGAL) and selection markers. For heterologous expression, similar approaches used for other yeast membrane proteins can be employed, including:
Episomal plasmids with selection markers for stable maintenance
Integration vectors for genomic insertion
Expression cassettes with epitope tags for detection and purification
When constructing recombinant S. cerevisiae strains, techniques similar to those used for other membrane proteins can be applied, including PCR amplification of the target gene and ligation into expression vectors with appropriate restriction sites, similar to methods used for other yeast proteins .
Verification of successful YPR071W expression can be accomplished through several complementary methods:
Western blot analysis using antibodies against epitope tags (such as His-tag) fused to YPR071W
Mass spectrometry identification of the expressed protein
Fluorescence microscopy of GFP-tagged YPR071W to confirm expression and localization
RT-PCR or qPCR to verify transcription of the gene
For tagged versions of the protein, western blot coupled with anti-His tag or other epitope-specific antibodies can confirm expression, similar to verification methods used for other recombinant yeast proteins .
Several genetic approaches can help elucidate YPR071W function:
Deletion mutant phenotypic analysis: Creating ypr071w∆ strains and assessing growth rates, stress responses, and other phenotypes under various conditions
Genetic interaction screens: Systematic deletion of YPR071W in combination with other gene deletions to identify genetic interactions
Suppressor screens: Identification of mutations that suppress phenotypes associated with YPR071W deletion
Overexpression studies: Examining phenotypic consequences of YPR071W overexpression
Similar approaches have been successfully used to characterize other previously uncharacterized yeast genes, such as YIL039W (later named TED1), which was found to function in trafficking pathways .
Protein-protein interaction studies are crucial for understanding YPR071W's functional context:
Affinity purification coupled with mass spectrometry (AP-MS): Using tagged YPR071W as bait to identify interaction partners
Yeast two-hybrid screening: Identifying direct protein interactions
Proximity-dependent biotin identification (BioID): Detecting proteins in close proximity to YPR071W
Co-immunoprecipitation: Validating specific protein-protein interactions
Analysis of such data can place YPR071W in a functional network, similar to how genetic interaction mapping positioned TED1 (YIL039W) within a functional pathway with Emp24p and Erv25p .
Determining subcellular localization is essential for understanding membrane protein function:
Fluorescence microscopy of GFP-tagged YPR071W
Immunofluorescence using antibodies against epitope-tagged YPR071W
Subcellular fractionation followed by western blotting
Density gradient centrifugation to separate cellular compartments
As demonstrated with other yeast membrane proteins, localization patterns can provide important functional insights. For example, ER localization might suggest roles in protein folding or early secretory pathway functions .
Membrane topology determination requires specialized approaches:
Protease protection assays: Determine which domains are accessible to proteases
Glycosylation mapping: Identify luminal domains using N-glycosylation site insertion
Cysteine accessibility methods: Use membrane-permeable and impermeable sulfhydryl reagents
Fluorescence protease protection (FPP) assay: Determine the orientation of protein domains
These methods help create a topological map showing how YPR071W spans the membrane, identifying cytosolic, transmembrane, and luminal domains.
Site-directed mutagenesis requires careful planning:
Identify conserved residues through sequence alignment with homologs
Target predicted functional domains or motifs
Consider the following mutation types:
Conservative substitutions to test specific chemical properties
Alanine scanning of specific regions
Domain deletions or swaps to test functional regions
Include appropriate controls (wild-type, known non-functional mutants)
Use quantitative phenotypic assays to measure effects
Mutational analysis should focus on potentially functional motifs identified in the YPR071W sequence, similar to structure-function studies that identified amino acid motifs in Kir channels .
Multi-omics approaches provide comprehensive insights:
| Approach | Methodology | Expected Outcomes |
|---|---|---|
| Transcriptomics | RNA-seq comparing WT vs ypr071w∆ | Genes differentially expressed upon YPR071W deletion |
| Proteomics | Quantitative MS comparing WT vs ypr071w∆ | Proteins with altered abundance or modification |
| Phosphoproteomics | Phosphopeptide enrichment + MS | Potential regulatory pathways affected |
| Metabolomics | LC-MS or GC-MS analysis | Metabolic pathways impacted by YPR071W |
Integration of these datasets can reveal functional pathways and processes in which YPR071W participates.
Comprehensive phenotypic profiling should include:
Growth rate determination under various conditions:
Different carbon sources (glucose, galactose, glycerol)
Osmotic stress (high salt, sorbitol)
pH variations
Temperature sensitivity
Presence of drugs or toxins
Cell morphology and cell cycle progression analysis
Stress response pathway activation
Membrane integrity assays
Growth assays similar to those used in identifying TED1 function can be applied, such as testing growth in high Na⁺ media or sensitivity to hygromycin B .
Genetic interaction mapping strategies include:
Systematic construction of double mutants (ypr071w∆ combined with other deletions)
Quantitative measurement of genetic interactions (negative/positive, synthetic lethality)
Epistasis mini-array profiling (E-MAP) to generate interaction profiles
Clustering analysis to identify functionally related genes
Similar approaches have successfully positioned uncharacterized genes in functional pathways, as demonstrated by the identification of TED1's relationship with Emp24p and Erv25p through E-MAP analysis and validation through complementary approaches .
Membrane protein purification requires specialized protocols:
Selection of appropriate detergents for solubilization (DDM, LMNG, etc.)
Affinity chromatography using tags (His, FLAG, etc.)
Size exclusion chromatography for further purification
Assessment of protein stability and homogeneity
Reconstitution into lipid nanodiscs or liposomes for functional studies
Protein storage considerations include buffer optimization (typically Tris-based with 50% glycerol) and temperature (-20°C for short-term, -80°C for extended storage) .
Several structural biology approaches can be applied:
X-ray crystallography (challenging but high resolution)
Cryo-electron microscopy (increasingly powerful for membrane proteins)
NMR spectroscopy (for specific domains or fragments)
Small-angle X-ray scattering (SAXS) for low-resolution envelope
Hydrogen-deuterium exchange mass spectrometry for dynamics
Computational structural prediction using AlphaFold2 or RoseTTAFold
Each method has strengths and limitations for membrane protein analysis, and a combination approach is often most informative.